We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma.
- Authors
Shah, N; Thall, P F; Fox, P S; Bashir, Q; Shah, J J; Parmar, S; Lin, P; Kebriaei, P; Nieto, Y; Popat, U R; Hosing, C M; Cornelison, A; Shpall, E J; Orlowski, R Z; Champlin, R E; Qazilbash, M H
- Abstract
A letter to the editor is presented on the phase I/II study which aims to determine the efficacy and safety of lenalidomide combined with high dosage of melphalan for the autologous transplantation of stem cell for the treatment of relapsed myeloma.
- Subjects
MULTIPLE myeloma treatment; ANTINEOPLASTIC agents; MELPHALAN
- Publication
Leukemia (08876924), 2015, Vol 29, Issue 9, p1945
- ISSN
0887-6924
- Publication type
Article
- DOI
10.1038/leu.2015.54